SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $213,000 | -59.0% | 7,751 | -50.6% | 0.00% | -66.7% |
| Q2 2019 | $520,000 | -35.6% | 15,701 | -31.8% | 0.00% | -40.0% |
| Q1 2019 | $807,000 | -10.2% | 23,038 | -14.9% | 0.01% | -16.7% |
| Q4 2018 | $899,000 | +11.3% | 27,063 | +68.7% | 0.01% | +50.0% |
| Q3 2018 | $808,000 | -29.4% | 16,039 | -16.1% | 0.00% | -42.9% |
| Q2 2018 | $1,144,000 | +20.2% | 19,108 | -20.0% | 0.01% | +40.0% |
| Q4 2017 | $952,000 | +4.0% | 23,887 | +4.4% | 0.01% | 0.0% |
| Q3 2017 | $915,000 | – | 22,880 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |